Tilak Healthcare, a start-up from the iBionext network developing medical video games for both the diagnosis and follow-up of chronic diseases, has secured funding of EUR2.5 million from iBionext Growth Fund.
The funds will help the company accelerate the development of its therapeutic mobile games, first targeting the ophthalmology field, with macular diseases.
The alliance of digital innovation and clinical expertise will allow Tilak Healthcare to offer screening and prevention solutions, thus leading to a better follow-up of many chronic diseases.
Edouard Gasser, CEO of Tilak Healthcare, says: “At Tilak we are proud to adapt the power of videogames and entertainment to healthcare, thanks to our very distinctive positioning in the digital health world. With the support of iBionext Growth Fund, we’ll make mobile gaming a great healthcare tool.”
Alexia Perouse, CEO of iBionext Growth Fund, says: “We strongly believe in Tilak Healthcare’s potential. The complete recruitment of the team marks the acceleration of the deployment of Tilak’s platform towards doctors and patients, it shows positive signals for our investment. The alliance of videogames and medicine offers great potential to make Tilak Healthcare a leader in therapeutic mobile games.”
